Clinical and genetic risk factors of self-reported penicillin allergy

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 1, 2008, Pages 152-158

  Apter, Andrea J ^a,b,c   Schelleman, Hedi ^b   Walker, Amy ^b   Addya, Kathakali ^c   Rebbeck, Timothy ^b  

^a Allergy   (United States)

^b Research on Therapeutics   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adverse drug reaction; drug allergy; genetics; IL 4; immediate hypersensitivity; Penicillin

Indexed keywords

PENICILLIN G;

ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; CALCULATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ISOLATION; FAMILY HISTORY; FEMALE; GENE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HYPOTENSION; IL4 GENE; IL4R GENE; IMMEDIATE TYPE HYPERSENSITIVITY; LACTB GENE; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; PENICILLIN ALLERGY; PRIORITY JOURNAL; RELATIVE; RISK FACTOR; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; URTICARIA; VOMITING; WHEEZING;

ADULT; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PENICILLINS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RECEPTORS, INTERLEUKIN-4; RIBOSOMAL PROTEINS; RISK FACTORS;

EID: 46049112865     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.03.037     Document Type: Article

References (38)

1. Adkinson Jr. N.F. Drug allergy. In: Adkinson N.F.J., Yunginger J.W., Busse W.W., Bochner B., Holgate S.T., and Simons F.E. (Eds). Middleton's allergy: principles and practice (2004), Elsevier, Philadelphia
2. Greenberger P.A. Drug allergy, part B: allergic reactions to individual drugs: low molecular weight. In: Grammer L.C., and Greenberger P.A. (Eds). Patterson's allergic diseases. 6th ed. (2002), Lippincott, Williams & Wilkins, Philadelphia 335-359
3. Saxon A., Beall G.N., Rohr A.S., and Adelman D.C. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 107 (1987) 204-215
4. Riedl M.A., and Casillas A.M. Adverse drug reactions: types and treatment options. Am Fam Physician 68 (2003) 1781-1790
5. Green G.R., Rosenblum A.H., and Sweet L.C. Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G: a cooperative prospective study of the penicillin study group of the American Academy of Allergy. J Allergy Clin Immunol 60 (1977) 339-345
6. Sogn D.D., Evans III R., Shepherd G.M., Casale T.B., Condemi J., Greenberger P.A., et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 152 (1992) 1025-1032
7. Fontaine C., Mayorga C., Bousquet P.J., Arnoux B., Torres M.J., Blanca M., et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy 62 (2007) 47-52
8. Salkind A.R., Cuddy P.G., and Foxworth J.W. The rational clinical examination: is this patient allergic to penicillin? an evidence-based analysis of the likelihood of penicillin allergy. JAMA 285 (2001) 2498-2505
9. Gadde J., Spence M., Wheeler B., and Adkinson Jr. N.F. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 270 (1993) 2456-2463
10. Levine B.B. Immunologic mechanisms of penicillin allergy: a haptenic model system for the study of allergic diseases of man. N Engl J Med 275 (1966) 1115-1125
11. Levine B.B., Redmond A.P., Fellner M.J., Voss H.E., and Levytska V. Penicillin allergy and the heterogenous immune responses of man to benzylpenicillin. J Clin Invest 45 (1966) 1895-1906
12. Levine B.B., and Zolov D.M. Prediction of penicillin allergy by immunological tests. J Allergy 43 (1969) 231-244
13. Parker C.W., Shapiro J., Kern M., and Eisen H.N. Hypersensitivity to penicillenic acid derivatives in human beings with penicillin allergy. J Exp Med 115 (1962) 821-838
14. Apter A.J., Kinman J.L., Bilker W., Herlim M., Margolis D.J., Lautenbach E., et al. Re-prescription of penicillin following allergic-like events. J Allergy Clin Immunol 113 (2004) 764-770
15. Apter A.J., Kinman J.L., Bilker W., Herlim M., Margolis D.J., Lautenbach E., et al. Is there cross-reactivity between penicillins and cephalosporins?. Am J Med 119 (2006) 354.e11-354.e20
16. Strom B.L., Schinnar R., Apter A.J., Margolis D.J., Lautenbach E., Hennessy S., et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 349 (2003) 1628-1635
17. Finkelman F.D., Rothenberg M.E., Brandt E.B., Morris S.C., and Strait R.T. Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol 115 (2005) 449-457
18. Abbas A.K., and Lichtman A.H. Cellular and molecular immunology, updated edition (2005), Elsevier Saunders, Philadelphia
19. Kerdine S., Lebrec H., Bertoglio J., and Pallardy M. Interleukin-4 plays a dominant role in Th1- or Th2-like responses during the primary immune response to the hapten penicillin. Mol Immunol 33 (1996) 71-77
20. Park J.S., Choi I.H., Lee D.G., Han S.S., Ha T.Y., Lee J.H., et al. Anti-IL-4 monoclonal antibody prevents antibiotics-induced active fatal anaphylaxis. J Immunol 158 (1997) 5002-5006
21. Yang J., Qiao H.L., and Dong Z.M. Polymorphisms of IL-13 and IL-4-IL-13-SNPs in patients with penicillin allergies. Eur J Clin Pharmacol 61 (2005) 803-809
22. Guglielmi L., Fontaine C., Gougat C., Avinens O., Eliaou J.F., Guglielmi P., et al. IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women. Allergy 61 (2006) 921-927
23. Qiao H.L., Wen Q., Gao N., Tian X., and Jia L.J. Association of IL-10 level and IL-10 promoter SNPs with specific antibodies in penicillin-allergic patients. Eur J Clin Pharmacol 63 (2007) 263-269
24. Goldstein D.B., Need A.C., Singh R., and Sisodiya S.M. Potential genetic causes of heterogeneity of treatment effects. Am J Med 120 (2007) S21-S25
25. Gilman A.G., Hardman J.G., and Limbird L.E. Chapter 44: penicillins, cephalosporins, and other beta-lactam antibiotics. In: Brunton L.L., Lazo J.S., Parker K.L., Buxton I.L., and Blumenthal D.K. (Eds). Goodman & Gilman's pharmacological basis of therapeutics. 11th ed. (2006), McGraw-Hill, New York
26. Gene Cards. Rehovot, Israel: Crown Human Genomics Center and Bioinformatics Unit of Weizmann Institute of Science. Available at: http://www.genecards.org. Accessed May 27, 2008.
27. Rebbeck T.R., Ambrosone C.B., Bell D.A., Chanock S.J., Hayes R.B., Kadlubar F.F., et al. SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 13 (2004) 681-687
28. Livak K.J., Marmaro J., and Todd J.A. Towards fully automated genome-wide polymorphism screening. Nat Genet 9 (1995) 341-342
29. Nosek L., Vassar D., Brown C., Bruek C., Buntaine B., Mueller E., et al. Whole genome amplification: applications testing with the GenomePlex system (2007), Sigma-Aldrich, St Louis (MO). http://www.sigmaaldrich.com/sigma/general%20information/wgaapplicationsposter.pdf Accessed May 22, 2008
30. Bergen A.W., Qi Y., Haque K.A., Welch R.A., and Chanock S.J. Effects of DNA mass on multiple displacement whole genome amplification and genotyping performance. BMC Biotechnol 5 (2005) 24
31. Murthy K.K., Mahboubi V.S., Santiago A., Barragan M.T., Knoll R., Schultheiss H.P., et al. Assessment of multiple displacement amplification for polymorphism discovery and haplotype determination at a highly polymorphic locus, MC1R. Hum Mutat 26 (2005) 145-152
32. De La Vega F.M., Isaac H.I., and Scafe C.R. A tool for selecting SNPs for association studies based on observed linkage disequilibrium patterns. Pac Symp Biocomput (2006) 487-498
33. Simons F.E., Frew A.J., Ansotegui I.J., Bochner B.S., Golden D.B., Finkelman F.D., et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 120 (2007) S2-S24
34. Greenberger P.A. Drug allergy. J Allergy Clin Immunol 117 (2006) S464-S470
35. Mazzaglia G., Caputi A.P., Rossi A., Bettoncelli G., Stefanini G., Ventriglia G., et al. Exploring patient- and doctor-related variables associated with antibiotic prescribing for respiratory infections in primary care. Eur J Clin Pharmacol 59 (2003) 651-657
36. Melnick S.L., Sprafka J.M., Laitinen D.L., Bostick R.M., Flack J.M., and Burke G.L. Antibiotic use in urban whites and blacks: the Minnesota Heart Survey. Ann Pharmacother 26 (1992) 1292-1295
37. Norris P., Becket G., and Ecke D. Demographic variation in the use of antibiotics in a New Zealand town. N Z Med J 118 (2005) U1352
38. Park M.A., Matesic D., Markus P.J., and Li J.T. Female sex as a risk factor for penicillin allergy. Ann Allergy Asthma Immunol 99 (2007) 54-58